Dry Powder Inhaler Market Size Forecast From 2026 To 2030: Key Industry Trends
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Dry Powder Inhaler Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The dry powder inhaler market has experienced consistent expansion recently. It will grow from $22.18 billion in 2025 to $23.25 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. This historical growth can be attributed to several factors, including the increasing occurrence of asthma and COPD, the broad adoption of inhalation therapy, advancements in dry powder formulation technologies, the expansion of home-based respiratory care, and the availability of economical inhaler devices.
The dry powder inhaler market size is anticipated to show steady development over the next few years. It is set to grow to $28.16 billion in 2030, at a compound annual growth rate (CAGR) of 4.9%. This expansion during the forecast period is propelled by the increasing integration of smart inhaler technologies, a rising focus on personalized respiratory care, the broadening scope of remote patient monitoring, a growing demand for environmentally friendly inhalers, and the increasing adoption of digital health ecosystems. Significant trends for the forecast period include the rising adoption of digitally operated inhalers, an increased demand for patient-adherence monitoring, an intensified focus on portable and user-friendly designs, the expansion of multi-dose inhaler platforms, and an enhanced emphasis on dose accuracy.
Get A Free Sample Report With In-Depth Market Insights:
Dry Powder Inhaler Market Industry Drivers: What’s Behind The Revenue Growth?
The expansion of the dry powder inhaler market is anticipated to be significantly boosted by the increasing occurrence of respiratory ailments. These illnesses, often referred to as respiratory disorders or lung diseases, encompass a broad spectrum of medical conditions affecting the respiratory system. Dry powder inhalers are vital in managing respiratory conditions such as asthma, COPD, and cystic fibrosis, as they deliver medication directly to the lungs for optimal effectiveness. They offer a promising alternative to traditional drug delivery methods for respiratory diseases. For instance, in December 2023, a research study published by JAMA Network Open, a medical journal by the American Medical Association, projected that the global burden of chronic obstructive pulmonary disease (COPD) could lead to nearly 600 million cases worldwide by 2050, representing a 23% increase in prevalence. Therefore, the growing prevalence of respiratory diseases will drive the growth of the dry powder inhaler market.
Dry Powder Inhaler Market Segment Analysis: What Are The Core Market Categories?
The dry powder inhaler market covered in this report is segmented –
1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers
2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single-Dose Inhalers: Capsule-Based Inhalers, Diskus-Based Inhalers
2) By Multi-Dose Inhalers: Blister-Based Inhalers, Rotahaler-Based Inhalers
#Dry Powder Inhaler Market Growth Trends: What’s Shaping The Future Outlook?
Leading firms in the dry powder inhaler market are creating novel products incorporating muscarinic antagonists to manage chronic obstructive pulmonary disease (COPD) and broaden their product offerings. A muscarinic antagonist refers to a medication that blocks the muscarinic acetylcholine receptor. This type of drug is effective in controlling and treating a range of conditions, including COPD and organophosphate poisoning. For example, in March 2024, Berry Global, a US-based company recognized for its development and production of diverse flexible packaging solutions, launched its latest dry powder inhaler at Pharmapack, signifying a strategic move into sophisticated drug-delivery technologies. This device is designed to enhance the effectiveness and uniformity of drug administration for respiratory ailments, especially COPD and asthma, where precise dosage and user-friendliness are essential. Its adaptable design enables pharmaceutical companies to customize the inhaler to meet particular formulation requirements, providing increased flexibility during product development. Through the integration of patient-focused features and flexible capabilities, Berry Global seeks to foster innovation within the respiratory therapeutics sector while reinforcing its position as a collaborator for pharmaceutical manufacturers.
Dry Powder Inhaler Market Leading Companies And Competitive Benchmarking
Major companies operating in the dry powder inhaler market are Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, Hovione, MannKind Corporation, Presspart Manufacturing Ltd, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.
View The Full Dry Powder Inhaler Market Report:
Dry Powder Inhaler Market Largest Region By Revenue And Market Share
North America was the largest region in the dry powder inhaler market in 2025. The regions covered in the dry powder inhaler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
